Old Web
English
Sign In
Acemap
>
authorDetail
>
Kiyofumi Sasai
Kiyofumi Sasai
Takeda Pharmaceutical Company
Anesthesia
Placebo
Internal medicine
Adverse effect
Clinical Global Impression
5
Papers
45
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Vortioxetine in Japanese Patients With Major Depressive Disorder.
2019
Psychiatry and Clinical Neurosciences
Takeshi Inoue
Kiyofumi Sasai
Tadayuki Kitagawa
Akira Nishimura
Isao Inada
Show All
Source
Cite
Save
Citations (6)
Randomized, 8-week, double-blind, placebo-controlled trial of vortioxetine in Japanese adults with major depressive disorder, followed by a 52-week open-label extension trial: Vortioxetine in Japanese MDD patients
2018
Psychiatry and Clinical Neurosciences
Takeshi Inoue
Akira Nishimura
Kiyofumi Sasai
Tadayuki Kitagawa
Show All
Source
Cite
Save
Citations (10)
Randomized, double‐blind, placebo‐controlled 8‐week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder
2018
Psychiatry and Clinical Neurosciences
Akira Nishimura
Yutaka Aritomi
Kiyofumi Sasai
Tadayuki Kitagawa
Atul R. Mahableshwarkar
Show All
Source
Cite
Save
Citations (14)
A randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-months depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer.
2016
Breast Cancer
Eiichi Shiba
Hiroko Yamashita
Junichi Kurebayashi
Shinzaburo Noguchi
Hirotaka Iwase
Yasuo Ohashi
Kiyofumi Sasai
Tsukasa Fujimoto
Show All
Source
Cite
Save
Citations (9)
Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
2012
Clinical Therapeutics
Hiromi Rakugi
Toshio Ogihara
Yuko Miyata
Kiyofumi Sasai
Nobuo Totsuka
Show All
Source
Cite
Save
Citations (6)
1